Representative before the EPO

Employment test 51 - 200 employees
Company dna mewburn ellis llp
operating since 1890
Headquarter in London and 4 offices
active in Legal Services

Seán Malcolm Walton has worked on the following 75 EPO patent applications which have been published in the last five years:

EP11754011

A NOVEL MUCOSAL VACCINATION APPROACH FOR HERPES SIMPLEX VIRUS TYPE-2

IPC classification:
A61K 31/7088, A61K 39/00, A61K 39/245, A61K 39/29, A61K 39/295, A61K 39/39
Agent:
Seán Malcolm Walton, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP11791675

SYSTEM AND METHOD FOR TRACKING ITEMS DURING A PROCESS

IPC classification:
G01N 35/00
Applicant:
Gen-Probe Incorporated
Agent:
Seán Malcolm Walton, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP11807478

METHOD AND FORMULATIONS FOR TREATING SIALIC ACID DEFICIENCIES

IPC classification:
A61K 9/00, A61K 9/20, A61K 9/22, A61K 31/7012, A61K 47/38, A61P 21/00
Agent:
Jacqueline Frances Moore, Cooley (UK) LLP
Agent:
Seán Malcolm Walton, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP12710732

ANTIBODY FC VARIANTS

IPC classification:
C07K 16/28
Applicant:
Roche Glycart AG
Agent:
Seán Malcolm Walton, Mewburn Ellis LLP
Agent:
Alexander Burger, Roche Diagnostics GmbH
Status:
GRANT OF PATENT INTENDED
EP11835004

IDENTIFICATION OF ANTIBODIES SPECIFIC FOR LYSSAVIRUSES AND METHODS OF THEIR USE

IPC classification:
A61K 39/395, C07K 16/00, C07K 16/10, C12N 15/13, C12N 15/85, G01N 33/53, G01N 33/569
Agent:
Seán Malcolm Walton, Mewburn Ellis LLP
Status:
The patent has been granted
EP12796089

BISMUTH PARTICLE X-RAY CONTRAST AGENTS

IPC classification:
A61K 49/04, A61L 31/18, B82Y 30/00, C07F 9/94, C08K 9/10
Applicant:
The Oregon State Board of Higher Education on Behalf of Portland State University
Agent:
Seán Malcolm Walton, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP12810873

IDENTIFICATION OF A WEST NILE VIRUS CD4 T CELL EPITOPE AND USE THEREOF

IPC classification:
C07K 14/18
Agent:
Seán Malcolm Walton, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12735490

IMMUNOCYTOKINE COMBINATION THERAPY

IPC classification:
A61K 38/20, A61K 47/48, C07K 14/525, C07K 14/54, C07K 16/18
Agent:
Multiple attorneys, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP12834632

SYSTEM AND METHOD FOR STABILIZING UNINTENTIONAL MUSCLE MOVEMENTS

IPC classification:
A61F 2/68
Applicant:
Verily Life Sciences LLC
Applicant:
Google Inc
Agent:
Rainer Gunzelmann, Wuesthoff & Wuesthoff Patentanwälte PartG mbB
Agent:
Malin Larsson, Awapatent AB
Agent:
Seán Malcolm Walton, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP12787079

FILL FORMULATIONS AND CAPSULES AND METHOD OF USE TO AVOID MIGRATION OF FILL INTO OR THROUGH THE SHELL

IPC classification:
A61B 5/08, A61B 5/083, A61J 3/07, A61K 9/48, A61K 47/08, A61K 47/10, A61K 47/38, A61K 49/00
Applicant:
Capsugel Belgium NV
Agent:
Seán Malcolm Walton, Mewburn Ellis LLP
Agent:
De Clercq & Partners cvba
Agent:
Andrea Macchetta, Capsugel Belgium NV
Status:
PATENT GRANTED
EP12841016

DENGUE VIRUS E-GLYCOPROTEIN POLYPEPTIDES CONTAINING MUTATIONS THAT ELIMINATE IMMUNODOMINANT CROSS-REACTIVE EPITOPES

IPC classification:
A61K 39/12, A61K 39/295, C07K 14/18, C12N 15/40
Agent:
Seán Malcolm Walton, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP12846033

PEPTIDES AND METHODS FOR THE DETECTION OF LYME DISEASE ANTIBODIES

IPC classification:
C07K 14/00, G01N 33/53, G01N 33/543
Agent:
Jacqueline Frances Moore, Cooley (UK) LLP
Agent:
Seán Malcolm Walton, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP14150323

Formulations for a tight junction effector

IPC classification:
A61K 9/16, A61K 9/50, A61K 38/08
Agent:
Seán Malcolm Walton, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP12852350

SIGNAL AMPLIFICATION IN LATERAL FLOW AND RELATED IMMUNOASSAYS

IPC classification:
G01N 33/53, G01N 33/543
Agent:
Jacqueline Frances Moore, Cooley (UK) LLP
Agent:
Seán Malcolm Walton, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP12852785

THERAPEUTIC AGENTS COMPRISING INSULIN AMINO ACID SEQUENCES

IPC classification:
A61K 38/00, A61K 38/28, C07H 21/04
Agent:
Cooley (UK) LLP
Agent:
Seán Malcolm Walton, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12852490

SYSTEMS AND METHODS FOR HIGH EFFICIENCY ELECTRONIC SEQUENCING AND DETECTION

IPC classification:
C12Q 1/68
Agent:
TLIP Limited
Agent:
Seán Malcolm Walton, Mewburn Ellis LLP
Status:
PATENT GRANTED
EP14163319

Transmucosal administration of drug compositions for treating and preventing disorders in animals

IPC classification:
A01N 25/00, A61K 9/00, A61K 9/12, A61K 31/4178, A61K 31/704, A61K 31/7048, A61K 38/13
Applicant:
Abbott Laboratories
Agent:
Seán Malcolm Walton, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12812999

MODIFIED CASCADE RIBONUCLEOPROTEINS AND USES THEREOF

IPC classification:
C07K 14/195, C12N 9/22, C12N 15/74
Applicant:
Wageningen University and Research Centre (Wageningen Universiteit)
Agent:
Martin Grund, Grund Intellectual Property Group
Agent:
James Christopher Legg, Avidity IP Ltd
Agent:
Seán Malcolm Walton, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13190343

Rapid cooling of body and/or brain by irrigating aerodigestive tract with cooling liquid

IPC classification:
A61F 7/00, A61F 7/12, A61H 35/00, A61M 16/04, A61M 19/00
Agent:
Seán Malcolm Walton, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13741129

FUSION PROTEINS COMPRISING IGG2 HINGE DOMAINS

IPC classification:
C07K 19/00
Applicant:
University of Maryland Baltimore
Agent:
Seán Malcolm Walton, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11743015

MEDIA, KITS, SYSTEMS AND METHODS FOR THE MICROPROPAGATION OF BAMBOO

IPC classification:
A01N 43/90, C12N 5/00
Agent:
Seán Malcolm Walton, Mewburn Ellis LLP
Status:
APPLICATION WITHDRAWN
EP11813988

PROGNOSTIC GENE SIGNATURES FOR NON-SMALL CELL LUNG CANCER

IPC classification:
C12Q 1/68, C40B 40/08, G01N 33/50, G01N 33/53
Agent:
Seán Malcolm Walton, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12792320

ANTIBODIES SPECIFIC FOR TGF-BETA

IPC classification:
A61K 39/00, C07K 16/22
Agent:
Seán Malcolm Walton, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP13764092

TOPICALLY ADMINISTERED STRONTIUM-CONTAINING COMPLEXES FOR TREATING PAIN, PRURITIS AND INFLAMMATION

IPC classification:
A61K 31/05, A61K 31/192, A61K 31/198, A61K 33/24
Agent:
Seán Malcolm Walton, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP12873622

METHODS OF TREATMENT WITH ARGININE DEIMINASE

IPC classification:
A61K 38/00, C07K 14/00
Agent:
Cooley (UK) LLP
Agent:
Seán Malcolm Walton, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13758533

USE OF THYMOSIN ALPHA FOR TREATMENT OF PURULENT RHINOSINUSITIS

IPC classification:
A61K 38/17, A61K 38/22, A61P 11/00
Agent:
Jacqueline Frances Moore, Cooley (UK) LLP
Agent:
Seán Malcolm Walton, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14189746

Methods and compositions for the diagnosis and treatment of lung cancer using KIT gene as genetic marker

IPC classification:
C12Q 1/68
Applicant:
Genentech, Inc.
Agent:
Seán Malcolm Walton, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13726394

SALMONELLA TYPHI TY21A EXPRESSING YERSINIA PESTIS F1-V FUSION PROTEIN AND USES THEREOF

IPC classification:
A61K 39/02, C12N 15/62
Applicant:
The United States of America as Represented by the Secretary, Department of Health and Human Services
Agent:
Seán Malcolm Walton, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP13804259

COMPOSITIONS AND METHODS FOR ENHANCING THE EFFICACY OF CONTRACEPTIVE MICROBICIDES

IPC classification:
A61K 9/10, A61K 9/14, A61K 38/00, A61P 31/18
Agent:
Seán Malcolm Walton, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP14188334

IMPROVED FORMULATIONS AND METHODS FOR LYOPHILIZATION AND LYOPHILATES PROVIDED THEREBY

IPC classification:
A61K 9/16, A61K 9/20, A61K 31/175
Agent:
Seán Malcolm Walton, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13810528

A CHEMICAL INDICATOR DEVICE

IPC classification:
G01N 21/01, G01N 21/25, G01N 30/74
Agent:
Seán Malcolm Walton, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP13837832

SENSING SYSTEM

IPC classification:
A61B 3/113, G02C 7/04
Applicant:
Verily Life Sciences LLC
Applicant:
Google Inc
Agent:
Matthias Alexander Frenkel, Wuesthoff & Wuesthoff Patentanwälte PartG mbB
Agent:
Seán Malcolm Walton, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP14165074

Predicting response to a HER dimerisation inhbitor based on low HER3 expression

IPC classification:
A61K 39/395, C12Q 1/68, G01N 33/574
Applicant:
F. Hoffmann-La Roche AG
Applicant:
Genentech, Inc.
Agent:
Seán Malcolm Walton, Mewburn Ellis LLP
Status:
APPLICATION WITHDRAWN
EP13771738

RECOMBINANT LACTOCOCCUS LACTIS EXPRESSING ESCHERICHIA COLI COLONIZATION FACTOR ANTIGEN I (CFA/I) FIMBRIAE AND THEIR METHODS OF USE

IPC classification:
A61K 35/74, A61K 39/108, A61P 37/06
Applicant:
Montana State University-Bozeman
Agent:
Seán Malcolm Walton, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP11838481

METHODS FOR DETERMINING DIFFERENCES IN ALPHA-4 INTEGRIN ACTIVITY BY CORRELATING DIFFERENCES IN sVCAM AND/OR sMAdCAM LEVELS

IPC classification:
A61K 39/395, G01N 33/566, G01N 33/68
Applicant:
Biogen MA Inc.
Applicant:
Elan Pharmaceuticals Inc.
Applicant:
Biogen Idec MA Inc.
Agent:
Multiple attorneys, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13846229

MICROELECTRODES IN AN OPHTHALMIC ELECTROCHEMICAL SENSOR

IPC classification:
G01N 27/26, G01N 33/48
Applicant:
Verily Life Sciences LLC
Applicant:
Google Inc
Agent:
Steffen J. Schmidt, Wuesthoff & Wuesthoff Patentanwälte PartG mbB
Agent:
Seán Malcolm Walton, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13851503

TEMPERATURE CHANGING INTRACORPOREAL FLUID DELIVERY DEVICES

IPC classification:
A61M 5/14, A61M 5/168, A61M 5/44, A61M 39/08, H05B 1/00
Agent:
Seán Malcolm Walton, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP12732263

GENERATION OF ANTIBODIES TO TUMOR ANTIGENS AND GENERATION OF TUMOR SPECIFIC COMPLEMENT DEPENDENT CYTOTOXICITY BY ADMINISTRATION OF ONCOLYTIC VACCINIA VIRUS

IPC classification:
A61K 35/76, A61K 39/12, A61P 35/00, C07K 16/30
Agent:
Seán Malcolm Walton, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP15163709

THERAPEUTIC AGENTS COMPRISING ELASTIN-LIKE PEPTIDES

IPC classification:
A61K 38/00, A61K 38/28, A61P 3/04, A61P 3/08, C07K 1/00
Applicant:
Duke University
Agent:
Cooley (UK) LLP
Agent:
Seán Malcolm Walton, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP13863494

METHODS FOR TREATING PRURITUS

IPC classification:
A01N 43/42, A61K 31/485, A61P 25/00
Agent:
Cooley (UK) LLP
Agent:
Seán Malcolm Walton, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13862044

TRIHEPTANOIN FOR THE TREATMENT OF GLUCOSE TRANSPORTER 1 DEFICIENCY

IPC classification:
A61K 31/225, A61K 31/23, A61P 3/00, A61P 3/02, A61P 25/08
Agent:
Cooley (UK) LLP
Agent:
Seán Malcolm Walton, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP14735408

THERAPEUTIC VACCINES FOR TREATING HERPES SIMPLEX VIRUS TYPE 2 INFECTIONS

IPC classification:
A61K 9/127, A61K 39/245
Agent:
Seán Malcolm Walton, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP14745410

IMMUNOGENIC COMPOSITIONS COMPRISING SILICIFIED VIRUS AND METHODS OF USE

IPC classification:
A61K 39/12
Applicant:
Portland State University
Agent:
Seán Malcolm Walton, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP15174585

INSULIN RECEPTOR BINDING ANTIBODIES

IPC classification:
A61K 39/395, A61P 3/10, C07K 16/26, C07K 16/28
Agent:
Seán Malcolm Walton, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP14769521

COMPOSITIONS AND METHODS FOR THE TREATMENT OF CARBOXYHEMOGLOBINEMIA

IPC classification:
A61K 38/41, A61P 39/02, C07K 14/795
Applicant:
University of Pittsburgh of the Commonwealth System of Higher Education
Agent:
Seán Malcolm Walton, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP14769754

IN VITRO PRODUCTION OF MEDIAL GANGLIONIC EMINENCE PRECURSOR CELLS

IPC classification:
C12N 5/00, C12N 5/02, C12N 5/071
Applicant:
The Regents of the University of California
Agent:
Seán Malcolm Walton, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP14774486

HIGH FAT HUMAN MILK PRODUCTS

IPC classification:
A23C 9/152, A23C 9/158
Agent:
Seán Malcolm Walton, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP14771135

COMPOSITIONS AND METHODS OF NUCLEIC ACID-TARGETING NUCLEIC ACIDS

IPC classification:
C12Q 1/68
Agent:
Martin Grund, Grund Intellectual Property Group
Agent:
Seán Malcolm Walton, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP14773031

ADULTERATION TESTING OF HUMAN MILK

IPC classification:
G01N 31/00, G01N 33/48
Agent:
Seán Malcolm Walton, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP14718255

METHODS FOR MODULATING CHEMOTHERAPEUTIC CYTOTOXICITY

IPC classification:
A61K 31/137, A61K 31/365, A61K 31/437, A61K 31/505, A61K 31/52, A61K 31/65, A61K 31/704, A61K 31/706, A61K 31/7064, A61K 31/711, A61K 31/712, A61K 39/395, A61P 35/00
Applicant:
The United States of America as Represented by the Secretary, Department of Health and Human Services
Agent:
Seán Malcolm Walton, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP14800396

DNA-GUIDED DNA INTERFERENCE BY A PROKARYOTIC ARGONAUTE

IPC classification:
C12Q 1/00
Agent:
Martin Grund, Grund Intellectual Property Group
Agent:
Seán Malcolm Walton, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP14783323

METHODS, USES AND COMPOSITIONS OF TIE2 AGONISTS

IPC classification:
A61K 31/13, A61K 31/195, A61K 31/216, A61K 31/351, A61K 31/7056, A61K 38/18, A61K 39/395, A61K 47/48, A61P 31/16
Agent:
Seán Malcolm Walton, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15150112

Combination therapies for B-cell lyphomas comprising administration of anti-CD20 antibody

IPC classification:
A61K 38/00, A61K 39/395, A61K 51/10, C07K 16/00, C07K 16/28, C07K 16/30
Applicant:
F. Hoffmann-La Roche AG
Applicant:
Biogen Inc.
Agent:
Seán Malcolm Walton, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP15185749

HUMANIZED ANTI-BETA7 ANTAGONISTS AND USES THEREFOR

IPC classification:
A61K 39/395, C07K 16/18, C07K 16/28
Applicant:
Genentech, Inc.
Agent:
Seán Malcolm Walton, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP14791718

SOBETIROME IN THE TREATMENT OF MYELINATION DISEASES

IPC classification:
A61K 38/24, A61P 25/00, A61P 25/28, C07C 59/48
Applicant:
Oregon Health & Science University
Applicant:
The United States of America Represented by the Department of Veterans Affairs
Agent:
Seán Malcolm Walton, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15180834

AVIRULENT, IMMUNOGENIC FLAVIVIRUS CHIMERAS

IPC classification:
A61K 39/12, A61K 39/295, C07K 14/18, C12N 7/01, C12N 15/40
Applicant:
Mahidol University
Agent:
Seán Malcolm Walton, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15178110

HUMANIZED ANTI-FACTOR D ANTIBODIES AND USES THEREOF

IPC classification:
A61P 27/02, C07K 16/18, G01N 33/53, G01N 33/68
Applicant:
Genentech, Inc.
Agent:
Seán Malcolm Walton, Mewburn Ellis LLP
Status:
APPLICATION WITHDRAWN
EP15189714

ANTI-FACTOR XI MONOCLONAL ANTIBODIES AND METHODS OF USE THEREOF

IPC classification:
A61K 39/00, A61K 39/395, A61K 45/06, C07K 16/36
Applicant:
Oregon Health & Science University
Applicant:
Vanderbilt University - Center for Technology Transfer and Commercialization (CTTC)
Agent:
Seán Malcolm Walton, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP14813015

SYMMETRICALLY ARRANGED SENSOR ELECTRODES IN AN OPHTHALMIC ELECTROCHEMICAL SENSOR

IPC classification:
A61F 2/14, G01N 27/26, G01N 27/416, G02C 7/04, G08C 17/00
Applicant:
Verily Life Sciences LLC
Agent:
Seán Malcolm Walton, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP15185944

RECURRENT GENE FUSIONS IN PROSTATE CANCER

IPC classification:
C12Q 1/68
Applicant:
The Regents of the University of Michigan
Agent:
Seán Malcolm Walton, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP12188676

Compositions of human lipids and methods of making and using same

IPC classification:
A23C 9/20, A61K 35/20, A23P 10/00, A23L 33/00
Agent:
Seán Malcolm Walton, Mewburn Ellis LLP
Status:
PATENT GRANTED
EP11810769

CELL SURFACE DISPLAY USING PDZ DOMAINS

IPC classification:
C12N 15/10, C40B 40/08
Agent:
Seán Malcolm Walton, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11706722

GENE SETS FOR DETECTION ULTRAVIOLET A EXPOSURE AND METHODS OF USE THEREOF

IPC classification:
C12Q 1/68
Applicant:
The United States of America as Represented by the Secretary, Department of Health and Human Services
Agent:
Seán Malcolm Walton, Mewburn Ellis LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12198382

Engineered constant domain molecule of an antibody

IPC classification:
C07K 16/00, C07K 16/10, C07K 19/00
Agent:
Seán Malcolm Walton, Mewburn Ellis LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12185486

Temporal release of growth factors from 3d micro rod scaffolds for tissue regeneration

IPC classification:
A61K 9/16, A61L 27/16
Applicant:
The Regents of the University of California
Applicant:
Board of Trustees of the University of Illinois
Agent:
Francesco Fiussello, Studio Torta SpA
Agent:
Seán Malcolm Walton, Mewburn Ellis LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12704201

METHODS AND MATERIALS FOR ENHANCING FUNCTIONAL PROTEIN EXPRESSION IN BACTERIA

IPC classification:
C07K 14/245, C12N 9/90, C12N 15/62, C12N 15/67
Agent:
Seán Malcolm Walton, Mewburn Ellis LLP
Status:
PATENT GRANTED
EP16169431

MODIFIED CASCADE RIBONUCLEOPROTEINS AND USES THEREOF

IPC classification:
C07K 14/195, C12N 9/22, C12N 15/74
Agent:
Martin Grund, Grund Intellectual Property Group
Agent:
Seán Malcolm Walton, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15740660

DIPEPTIDYL PEPTIDASE-4 (DPP4/CD26) AS A PERIPHERAL BIOMARKER OF IL-13 ACTIVATION IN ASTHMATIC LUNG

IPC classification:
A61K 39/395, G01N 33/53, G01N 33/573
Applicant:
MedImmune, LLC
Agent:
Seán Malcolm Walton, Mewburn Ellis LLP
Agent:
Valérie Marie-Noëlle Meyrial, MedImmune Limited
Status:
EXAMINATION REQUESTED
EP15706093

NOVEL ASSAY TO DETECT HUMAN PERIOSTIN

IPC classification:
C07K 16/18, G01N 33/68
Applicant:
Abbott Laboratories
Applicant:
MedImmune, LLC
Agent:
Seán Malcolm Walton, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15706091

NOVEL ASSAY TO DETECT HUMAN PERIOSTIN

IPC classification:
C07K 16/18, G01N 33/68
Applicant:
MedImmune, LLC
Agent:
Seán Malcolm Walton, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP10844862

CYTOMEGALOVIRUS-BASED IMMUNOGENIC PREPARATIONS

IPC classification:
C07K 14/045, G01N 33/15, G01N 33/569, G01N 33/574
Applicant:
Oregon Health & Science University
Agent:
Seán Malcolm Walton, Mewburn Ellis LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11706690

NEUREGULIN ANTAGONISTS AND USE THEREOF IN TREATING CANCER

IPC classification:
A61K 31/7088, A61K 38/17, A61K 39/395, A61K 45/06, A61P 35/00, C07K 14/475, C07K 14/71, C12N 15/113, C12N 15/62
Applicant:
Genentech, Inc.
Applicant:
The Board of Trustees of the Leland Stanford Junior University
Agent:
Seán Malcolm Walton, Mewburn Ellis LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP16199297

SCREENING METHODS

IPC classification:
G01N 33/557, G01N 33/68
Agent:
Seán Malcolm Walton, Mewburn Ellis LLP
Status:
APPLICATION PUBLISHED
EP16198600

EXTENDING TIME TO DISEASE PROGRESSION OR SURVIVAL IN CANCER PATIENTS

IPC classification:
A61K 31/7068, A61K 39/00, A61K 39/395, A61K 45/06, A61P 35/00, C07K 16/30, C07K 16/32
Applicant:
Genentech, Inc.
Agent:
Seán Malcolm Walton, Mewburn Ellis LLP
Status:
The application has been published
EP15788253

METHODS TO ELIMINATE CANCER STEM CELLS BY TARGETING CD47

IPC classification:
A61K 39/00, C07K 16/28, C07K 16/30
Agent:
Seán Malcolm Walton, Mewburn Ellis LLP
Status:
Request for examination was made

Please Sign in to use this feature